Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T02:04:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T02:04:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov release identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:52:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T02:17:19.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a new Revision: v3.7.0 entry to the study record history, indicating a new version of the record has been posted. The previous Revision: v3.6.6 entry was removed from the history table.
    Difference
    0.1%
    Check dated 2026-09-20T01:11:42.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 has been added to the record history, replacing the previous v3.6.5 entry. This reflects an update to the page’s versioning rather than changes to the trial data.
    Difference
    0.1%
    Check dated 2026-08-29T22:11:08.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.